Logo image of JELD

JELD-WEN HOLDING INC (JELD) Stock Fundamental Analysis

USA - NYSE:JELD - US47580P1030 - Common Stock

4.965 USD
-0.11 (-2.07%)
Last: 9/29/2025, 3:21:04 PM
Fundamental Rating

2

Taking everything into account, JELD scores 2 out of 10 in our fundamental rating. JELD was compared to 41 industry peers in the Building Products industry. Both the profitability and financial health of JELD have multiple concerns. JELD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year JELD was profitable.
JELD had a positive operating cash flow in the past year.
Of the past 5 years JELD 4 years were profitable.
In the past 5 years JELD always reported a positive cash flow from operatings.
JELD Yearly Net Income VS EBIT VS OCF VS FCFJELD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

JELD has a worse Return On Assets (-13.94%) than 82.93% of its industry peers.
JELD has a worse Return On Equity (-74.29%) than 90.24% of its industry peers.
Industry RankSector Rank
ROA -13.94%
ROE -74.29%
ROIC N/A
ROA(3y)-1.27%
ROA(5y)0.6%
ROE(3y)-5.61%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
JELD Yearly ROA, ROE, ROICJELD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

In the last couple of years the Operating Margin of JELD has declined.
With a Gross Margin value of 16.96%, JELD is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
JELD's Gross Margin has declined in the last couple of years.
JELD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.96%
OM growth 3Y-44.57%
OM growth 5Y-27.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.71%
GM growth 5Y-2.15%
JELD Yearly Profit, Operating, Gross MarginsJELD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

JELD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JELD has been reduced compared to 1 year ago.
Compared to 5 years ago, JELD has less shares outstanding
Compared to 1 year ago, JELD has a worse debt to assets ratio.
JELD Yearly Shares OutstandingJELD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
JELD Yearly Total Debt VS Total AssetsJELD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

JELD has an Altman-Z score of 1.56. This is a bad value and indicates that JELD is not financially healthy and even has some risk of bankruptcy.
JELD has a worse Altman-Z score (1.56) than 85.37% of its industry peers.
JELD has a Debt/Equity ratio of 2.42. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.42, JELD is not doing good in the industry: 90.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.42
Debt/FCF N/A
Altman-Z 1.56
ROIC/WACCN/A
WACC7.68%
JELD Yearly LT Debt VS Equity VS FCFJELD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JELD has a Current Ratio of 1.77. This is a normal value and indicates that JELD is financially healthy and should not expect problems in meeting its short term obligations.
JELD has a worse Current ratio (1.77) than 60.98% of its industry peers.
A Quick Ratio of 1.04 indicates that JELD should not have too much problems paying its short term obligations.
JELD has a worse Quick ratio (1.04) than 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.04
JELD Yearly Current Assets VS Current LiabilitesJELD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1

3. Growth

3.1 Past

The earnings per share for JELD have decreased strongly by -99.31% in the last year.
JELD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.18% yearly.
The Revenue for JELD has decreased by -15.16% in the past year. This is quite bad
JELD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.52% yearly.
EPS 1Y (TTM)-99.31%
EPS 3Y-24.51%
EPS 5Y-8.18%
EPS Q2Q%-111.76%
Revenue 1Y (TTM)-15.16%
Revenue growth 3Y-7.51%
Revenue growth 5Y-2.52%
Sales Q2Q%-16.46%

3.2 Future

JELD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.42% yearly.
Based on estimates for the next years, JELD will show a decrease in Revenue. The Revenue will decrease by -2.59% on average per year.
EPS Next Y-94.13%
EPS Next 2Y-27.86%
EPS Next 3Y-3.42%
EPS Next 5YN/A
Revenue Next Year-12.88%
Revenue Next 2Y-5.56%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
JELD Yearly Revenue VS EstimatesJELD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
JELD Yearly EPS VS EstimatesJELD Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 496.50, JELD can be considered very expensive at the moment.
Based on the Price/Earnings ratio, JELD is valued more expensive than 80.49% of the companies in the same industry.
JELD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
A Price/Forward Earnings ratio of 12.39 indicates a correct valuation of JELD.
JELD's Price/Forward Earnings ratio is rather cheap when compared to the industry. JELD is cheaper than 80.49% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.05. JELD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 496.5
Fwd PE 12.39
JELD Price Earnings VS Forward Price EarningsJELD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JELD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.05
JELD Per share dataJELD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

JELD's earnings are expected to decrease with -3.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.86%
EPS Next 3Y-3.42%

0

5. Dividend

5.1 Amount

No dividends for JELD!.
Industry RankSector Rank
Dividend Yield N/A

JELD-WEN HOLDING INC

NYSE:JELD (9/29/2025, 3:21:04 PM)

4.965

-0.11 (-2.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners92.67%
Inst Owner Change-6.94%
Ins Owners1.96%
Ins Owner Change7.14%
Market Cap424.01M
Analysts50
Price Target4.87 (-1.91%)
Short Float %2.02%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.45%
Min EPS beat(2)11.91%
Max EPS beat(2)50.98%
EPS beat(4)2
Avg EPS beat(4)-5.69%
Min EPS beat(4)-63.4%
Max EPS beat(4)50.98%
EPS beat(8)6
Avg EPS beat(8)12.41%
EPS beat(12)10
Avg EPS beat(12)60.7%
EPS beat(16)11
Avg EPS beat(16)41.57%
Revenue beat(2)0
Avg Revenue beat(2)-0.55%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-7.55%
Max Revenue beat(4)1.9%
Revenue beat(8)2
Avg Revenue beat(8)-1.6%
Revenue beat(12)5
Avg Revenue beat(12)-0.46%
Revenue beat(16)6
Avg Revenue beat(16)-2.11%
PT rev (1m)0%
PT rev (3m)10.75%
EPS NQ rev (1m)29.73%
EPS NQ rev (3m)50.7%
EPS NY rev (1m)193.95%
EPS NY rev (3m)129.33%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)3.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.35%
Valuation
Industry RankSector Rank
PE 496.5
Fwd PE 12.39
P/S 0.12
P/FCF N/A
P/OCF 25.08
P/B 0.89
P/tB 2.35
EV/EBITDA 15.05
EPS(TTM)0.01
EY0.2%
EPS(NY)0.4
Fwd EY8.07%
FCF(TTM)-1.86
FCFYN/A
OCF(TTM)0.2
OCFY3.99%
SpS40.17
BVpS5.59
TBVpS2.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.94%
ROE -74.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.96%
FCFM N/A
ROA(3y)-1.27%
ROA(5y)0.6%
ROE(3y)-5.61%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.38%
ROCE(5y)6.41%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-44.57%
OM growth 5Y-27.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.71%
GM growth 5Y-2.15%
F-Score2
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 2.42
Debt/FCF N/A
Debt/EBITDA 11.77
Cap/Depr 158.55%
Cap/Sales 5.12%
Interest Coverage N/A
Cash Conversion 17.22%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.04
Altman-Z 1.56
F-Score2
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)95.72%
Cap/Depr(5y)86.36%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.31%
EPS 3Y-24.51%
EPS 5Y-8.18%
EPS Q2Q%-111.76%
EPS Next Y-94.13%
EPS Next 2Y-27.86%
EPS Next 3Y-3.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.16%
Revenue growth 3Y-7.51%
Revenue growth 5Y-2.52%
Sales Q2Q%-16.46%
Revenue Next Year-12.88%
Revenue Next 2Y-5.56%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A
EBIT growth 1Y-114.66%
EBIT growth 3Y-48.73%
EBIT growth 5Y-29.71%
EBIT Next Year6604.38%
EBIT Next 3Y369.18%
EBIT Next 5YN/A
FCF growth 1Y-164.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.16%
OCF growth 3Y-15.45%
OCF growth 5Y-18.9%